Sign in
4

Changes in Ownership

Odyssey Health, Inc. Filed Acc 0001683168-24-000340

Options or other derivatives

  • Chief Commerical Officer acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Emerson Erik C. Chief Commerical Officer 2024-01-16 Grant or award · Stock Option (Right to Buy) +37,500 $0.09 $3,188 37,500 D: show line 1 in the form
Loading xslF345X05/ownership.xml…